BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12970736)

  • 1. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
    Heckman CA; Wheeler MA; Boxer LM
    Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
    Heckman CA; Duan H; Garcia PB; Boxer LM
    Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.
    Heckman CA; Cao T; Somsouk L; Duan H; Mehew JW; Zhang CY; Boxer LM
    Cancer Res; 2003 Oct; 63(20):6666-73. PubMed ID: 14583460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
    Heckman CA; Mehew JW; Boxer LM
    Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
    Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBP alpha and beta mimic retinoic acid activation of IGFBP-5 in neuroblastoma cells by a mechanism independent from binding to their site.
    Cesi V; Giuffrida ML; Vitali R; Tanno B; Mancini C; Calabretta B; Raschellà G
    Exp Cell Res; 2005 Apr; 305(1):179-89. PubMed ID: 15777798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the Xenopus CCAAT-enhancer binding protein beta gene promoter.
    Foka P; Kousteni S; Ramji DP
    Biochem Biophys Res Commun; 2001 Jul; 285(2):430-6. PubMed ID: 11444861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.
    Arcinas M; Heckman CA; Mehew JW; Boxer LM
    Cancer Res; 2001 Jul; 61(13):5202-6. PubMed ID: 11431360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
    Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
    Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/enhancer binding protein beta mediates the activation of the murine alpha1(I) collagen promoter by acetaldehyde.
    Attard FA; Wang L; Potter JJ; Rennie-Tankersley L; Mezey E
    Arch Biochem Biophys; 2000 Jun; 378(1):57-64. PubMed ID: 10871045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential gene promoter interactions by C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis.
    Tang QQ; Zhang JW; Daniel Lane M
    Biochem Biophys Res Commun; 2004 May; 318(1):213-8. PubMed ID: 15110775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP.
    Johansson-Haque K; Palanichamy E; Okret S
    J Mol Endocrinol; 2008 Oct; 41(4):239-49. PubMed ID: 18682532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CCAAT enhancer binding protein alpha binding sites on the human alpha-fetoprotein gene.
    Li HM; Ikeda H; Nakabayashi H; Nishi S; Sakai M
    Gene; 2007 Mar; 389(2):128-35. PubMed ID: 17188819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
    Klick DE; Shadley JD; Hines RN
    Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene.
    Hua C; Zorn S; Jensen JP; Coupland RW; Ko HS; Wright JJ; Bakhshi A
    Oncogene Res; 1988 Feb; 2(3):263-75. PubMed ID: 3285301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.